Oncogenic Epidermal Growth Factor Receptor Silencing in Cervical Carcinoma Mediated by Dynamic Sugar-Benzoxaborole...

Area of Science:

• Biomaterials Science
• Cancer Gene Therapy
• Polymer Chemistry

Background:

• Cervical cancer treatments face challenges including side effects, toxicity, and multidrug resistance.
• Targeting the epidermal growth factor receptor (EGFR) offers a potential strategy for cancer therapy.
• Developing effective and safe delivery systems for gene-silencing agents is crucial.

Purpose of the Study:

• To synthesize novel RAFT-made, biocompatible, cationic polymers for siRNA delivery.
• To engineer a polymer vector with an oxaborole group responsive to acidic tumor microenvironments.
• To evaluate the efficacy and cytotoxicity of the developed vector for EGFR gene silencing in cancer cells.

Main Methods:

• Synthesis of RAFT-made cationic polymers with oxaborole modification via thiol-ene click chemistry.
• Encapsulation of small interfering RNA (siRNA) targeting the EGFR gene.
• Assessment of gene silencing efficacy using Western blot analysis.
• Evaluation of system cytotoxicity.

Main Results:

• Successful synthesis of dual-capability polymer vectors capable of complexing siRNA.
• Demonstrated siRNA release in a mild acidic environment, characteristic of tumor microenvironments.
• Achieved enhanced EGFR gene silencing without significant increase in cytotoxicity.
• Validated the potential of boron-carbohydrate interactions in nonviral vector development.

Conclusions:

• Novel RAFT-made polymers effectively deliver siRNA for EGFR gene silencing in cancer cells.
• The oxaborole modification enables environment-specific siRNA release, enhancing therapeutic potential.
• This boron-carbohydrate-based strategy presents a promising, less cytotoxic approach for nonviral gene therapy in cervical cancer.